Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01158001 · ClinicalTrials.gov registry record · NA
Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder
A NA study of Depression and Anxiety, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
- 1
- Study location
NCT01158001: Completed NA study of Depression and Anxiety, sponsored by Veterans Medical Research Foundation.
NCT01158001 is a NA study of Depression and Anxiety that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 211 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01158001, a NA study of Depression and Anxiety, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the proposed study is to conduct a systematic comparison of post traumatic stress disorder (PTSD) outcomes for veterans receiving exposure therapy via telemedicine versus in-person care. The primary aim is to determine feasibility: whether telemedicine can be used as a tool to extend effective, specialized mental health services, such as Prolonged Exposure therapy (PE; a therapy designed to help clients face fears related to a traumatic event), to veterans with limited access to care. A secondary aim is to determine if therapy delivered by telemedicine affects the quality of care in terms of clinical outcomes and the quality of patient-therapist interaction. A tertiary aim is to examine whether results from neuropsychological testing predict treatment outcomes.
Primary Outcome
Measure of PTSD diagnosis and severity
Conditions Studied
Interventions
- BEHAVIORAL Prolonged exposure therapy
Study Locations (1)
California
- VA San Diego Healthcare System - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01158001 record still lists
NCT01158001 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (73% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Prolonged exposure therapy is the first listed.
NCT01158001 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01158001 about?
NCT01158001 is a clinical study titled "Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder". The objective of the proposed study is to conduct a systematic comparison of post traumatic stress disorder (PTSD) outcomes for veterans receiving exposure therapy via telemedicine versus in-person care. The primary aim is to determine feasibility: whether telemedicine can be used as a tool to exten...
What is the current status of trial NCT01158001?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2009-05. Estimated completion is 2012-09.
What conditions does trial NCT01158001 study?
This clinical trial studies the following conditions: Depression, Anxiety, Post-Traumatic Stress Disorders.
What interventions are being tested in trial NCT01158001?
The interventions under investigation include: Prolonged exposure therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01158001?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01158001 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01158001's enrollment target sits among peer trials
211 201st of 679 higher than 479 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia